MXD3 and cancer: In addition, research has demonstrated that MXD3 loss has a significant impact on the stem cell features of PRAD cells.[27] As an additional point of interest, MXD3, which is classified as an onco-immunological biomarker, has been linked to the microenvironment of the tumor, as well as to prognoses, disease stage, and individual responses to various cancer treatments.